Yasushi Sakata
Yasushi Sakata
cardiology.med.osaka-u.ac.jp üzerinde doğrulanmış e-posta adresine sahip
Alıntı yapanlar
Alıntı yapanlar
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study
V Cheng, R Kazanagra, A Garcia, L Lenert, P Krishnaswamy, N Gardetto, ...
Journal of the American College of Cardiology 37 (2), 386-391, 2001
Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy
H Yamaguchi, J Yoshida, K Yamamoto, Y Sakata, T Mano, N Akehi, ...
Journal of the American College of Cardiology 43 (1), 55-60, 2004
Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of angiotensin-converting …
Y Sakata, K Yamamoto, T Mano, N Nishikawa, J Yoshida, M Hori, T Miwa, ...
Circulation 109 (17), 2143-2149, 2004
Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation
T Murakawa, O Yamaguchi, A Hashimoto, S Hikoso, T Takeda, T Oka, ...
Nature communications 6 (1), 1-14, 2015
Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart
K Yamamoto, T Masuyama, Y Sakata, N Nishikawa, T Mano, J Yoshida, ...
Cardiovascular research 55 (1), 76-82, 2002
Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry)
N Sato, K Kajimoto, T Keida, M Mizuno, Y Minami, D Yumino, K Asai, ...
Circulation Journal 77 (4), 944-951, 2013
Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats
R Doi, T Masuyama, K Yamamoto, Y Doi, T Mano, Y Sakata, K Ono, ...
Journal of hypertension 18 (1), 111-120, 2000
AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure
J Yoshida, K Yamamoto, T Mano, Y Sakata, N Nishikawa, M Nishio, ...
Hypertension 43 (3), 686-691, 2004
Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury
Y Sakata, JW Dong, JG Vallejo, CH Huang, JS Baker, KJ Tracey, ...
American Journal of Physiology-Heart and Circulatory Physiology 292 (1 …, 2007
Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive
JP Greenwood, EM Scott, JB Stoker, DASG Mary
Journal of the American College of Cardiology 38 (6), 1711-1717, 2001
Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction
T Ohtani, SF Mohammed, K Yamamoto, SM Dunlay, SA Weston, Y Sakata, ...
European heart journal 33 (14), 1742-1749, 2012
Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension
T Hashimoto-Kataoka, N Hosen, T Sonobe, Y Arita, T Yasui, T Masaki, ...
Proceedings of the National Academy of Sciences 112 (20), E2677-E2686, 2015
Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation
N Nishikawa, K Yamamoto, Y Sakata, T Mano, J Yoshida, T Miwa, ...
Cardiovascular research 57 (3), 766-774, 2003
Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: beneficial effects of mineralocorticoid receptor blocker
T Ohtani, M Ohta, K Yamamoto, T Mano, Y Sakata, M Nishio, Y Takeda, ...
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2007
Effects of drought on mesophyll conductance and photosynthetic limitations at different tree canopy layers
Plant, Cell & Environment 36 (11), 1961-1980, 2013
Safety and efficacy of autologous skeletal myoblast sheets (TCD-51073) for the treatment of severe chronic heart failure due to ischemic heart disease
Y Sawa, Y Yoshikawa, K Toda, S Fukushima, K Yamazaki, M Ono, ...
Circulation Journal 79 (5), 991-999, 2015
Toll-Like Receptor 2 Mediates Staphylococcus aureus–Induced Myocardial Dysfunction and Cytokine Production in the Heart
P Knuefermann, Y Sakata, JS Baker, CH Huang, K Sekiguchi, ...
Circulation 110 (24), 3693-3698, 2004
Phase I clinical trial of autologous stem cell–sheet transplantation therapy for treating cardiomyopathy
S Miyagawa, K Domae, Y Yoshikawa, S Fukushima, T Nakamura, A Saito, ...
Journal of the American Heart Association 6 (4), e003918, 2017
Transforming growth factor-β receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor
Y Sakata, AL Chancey, VG Divakaran, K Sekiguchi, N Sivasubramanian, ...
Basic research in cardiology 103 (1), 60-68, 2008
Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats
Y Sakata, T Masuyama, K Yamamoto, N Nishikawa, H Yamamoto, ...
Circulation 102 (18), 2269-2275, 2000
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20